PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.19%
Revenue growth of 6.19% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
2.25%
Gross profit growth of 2.25% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
4.51%
EBIT growth of 4.51% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
4.40%
Operating income growth of 4.40% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
-2.80%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-2.81%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-2.81%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
-0.00%
Share reduction while Healthcare median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
-0.00%
Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.34%
10Y CAGR of 55.34% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
55.34%
5Y revenue/share growth exceeding 1.5x Healthcare median of 2.47%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
55.34%
3Y CAGR of 55.34% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.68%
Net income/share CAGR exceeding 1.5x Healthcare median of 46.44% over a decade. Joel Greenblatt might see a standout compounder of earnings.
152.68%
5Y net income/share CAGR > 1.5x Healthcare median of 39.95%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
152.68%
3Y net income/share CAGR > 1.5x Healthcare median of 30.62%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
82.37%
Equity/share CAGR of 82.37% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
82.37%
5Y equity/share CAGR of 82.37% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
82.37%
3Y equity/share CAGR of 82.37% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.19%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
-2.57%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
4.07%
BV/share growth of 4.07% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-13.18%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.